Ananda launches cannabinoid medicines for chronic pain
LONDON, UK: Ananda Development Plc, a company developing cannabinoid-based medicines for complex, chronic inflammatory pain conditions, has launched its first two products MRX1 and MRX2 on the UK specials market. The products are oil formulations containing cannabidiol (CBD), a non-psychoactive…